Tribunal overturns ruling in sugar case
Listen to article
The Competition Appellate Tribunal, while deciding the appeals filed by the Pakistan Sugar Mills Association (PSMA) and its member mills, has sent back the case involving a penalty of Rs44 billion to the Competition Commission of Pakistan (CCP) for a fresh hearing.
In its short order, the tribunal directed that the matter be reheard by either the chairperson or any other member of the commission who was not a signatory to the earlier conflicting opinions and a final decision should be made preferably within 90 days.
The CCP's original 2021 order was issued by a four-member bench that was evenly split. Two members, including the then chairperson Rahat Kaunain Hassan and member Mujatba Lodhi, supported the imposition of the penalty while the remaining two including Bushra Naz Malik and Shaista Bano wrote a dissenting note.
To break the deadlock, the then chairperson exercised the "casting vote" under sub-section 5 of Section 24 of the Competition Act 2010 through a note dated August 13, 2021, effectively converting the stalemate into a majority ruling that upheld the penalty.
The legality of the casting vote became the central issue in the appeals filed by millers. The tribunal has ruled that the chairperson has no authority to exercise a casting vote in quasi-judicial proceedings under the Competition Act. As a result, the chairperson's opinion based on the casting vote has been set aside.
After fresh hearing, the decision of the chairperson or the assigned member will settle the matter and determine the violation of competition law by the PSMA and its member mills.
The appellate tribunal has recently become fully functional following the federal government's appointment of a new chairman, allowing the tribunal to resume hearing on several long-pending appeals.
In the sugar cartel case, the CCP had imposed penalties of Rs44 billion on the millers' association and 81 of its members. PSMA and its members had allegedly formed a cartel to manipulate prices and had collectively decided to export the sweetener. The CCP passed the order for violating Section 4 of the Competition Act.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
12 hours ago
- Business Recorder
Weekly SPI up by 0.02pc
ISLAMABAD: The SPI for the current week ended on June 04, 2025 increased by 0.02 percent. An increase is observed in the prices of tomatoes (16.94 percent), potatoes (11.52 percent), onions (5.21 percent), bananas (1.57 percent), eggs (1.34 percent), sugar (1.24 percent), rice basmati broken (1.02 percent), gur (0.81 percent), masoor (0.65 percent), milk fresh (0.47 percent), maash (0.46 percent), pulse gram (0.44 percent) and petrol (0.41 percent), says Pakistan Bureau of Statistics (PBS). The Year-on-Year trend depicts decrease of 0.02 percent. The major increase is observed in ladies sandal (55.62 percent), eggs (35.36 percent), moong (31.74 percent), powdered milk (23.82 percent), sugar (23.51 percent), beef (17.51 percent), bananas (17.29 percent), pulse gram (15.91 percent), chicken (15.88 percent), LPG (15.31 percent), vegetable ghee 2.5kg (13.56 percent) and vegetable ghee 1kg (12.49 percent), while major decrease is observed in the prices of onions (64.90 percent), electricity charges for q1 (36.54 percent), garlic (27.79 percent), potatoes (23.15 percent), tomatoes (18.10 percent), maash (17.99 percent), tea Lipton (17.93 percent), wheat flour (14.10 percent), chilies powder (5.74 percent), diesel (5.68 percent), rice Irri (5.56 percent), masoor(5.47 percent) and petrol (5.41 percent). During the week, out of 51 items, prices of 18 (35.29 percent) items increased, six (11.77 percent) items decreased and 27 (52.94 percent) items remained stable. The SPI for the consumption group up to Rs17,732, Rs17,732-Rs22,888, Rs22,889-Rs29,517, Rs29,518-Rs44,175 and above Rs44,175 increased by 0.28 percent, 0.18 percent, 0.10 percent, 0.04 percent and 0.05 percent respectively. The items prices of which increased during the period under review include, tomatoes 1kg (18.10 percent), potatoes 1kg (23.15 percent), onions 1kg (64.90 percent, bananas (kela) local 1 dozen (17.29 percent), eggs hen (farm) 1 dozen (1.34 percent), sugar refined 1kg (1.24 percent), rice basmati broken (average quality) 1kg (1.02 percent), gur (average quality) 1kg (0.81 percent), masoor (washed) 1kg (0.65 percent), milk fresh (un-boiled) 1 litre (0.47 percent), maash (washed) 1kg (0.46 percent), pulse gram 1kg (0.44 percent), petrol super per litre (0.41 percent), wheat flour bag 20kg (0.41 percent), moong (washed) 1kg (0.21 percent), shirting (average quality) 1 mtr (0.15 percent), rice IRRI-6/9 (Sindh/Punjab) 1kg (0.13 percent), and mustard oil (average quality)1kg (0.05 percent). Copyright Business Recorder, 2025
Business Recorder
12 hours ago
- Business Recorder
Pharmaceutical sector: CCP grants six exemptions to undertakings for FY2024–25
ISLAMABAD: In line with its mandate to promote fair competition and protect consumer welfare, the Competition Commission of Pakistan (CCP) has granted six exemptions to undertakings in the pharmaceutical sector for the fiscal year 2024–25, under Section 5 of the Competition Act, 2010. These exemptions relate to specific restrictive clauses in commercial agreements — such as territorial exclusivity and non-compete provisions that would ordinarily be considered anti-competitive under Section 4 (Prohibited Agreements) of the Act. However, after conducting rigorous due diligence, including a detailed assessment of market structures, sector-specific regulations, and the commercial terms of the agreements, CCP determined that the arrangements in question contribute to production efficiency, technological advancement, and enhanced consumer access to critical pharmaceutical products. The Commission noted that these exemptions are expected to improve service delivery, increase the availability of medicines in underserved regions, and lead to better public health outcomes. Consumers stand to benefit from access to advanced pharmaceutical technologies, more reliable product information, and higher standards of service. Each exemption was granted for a specific duration and is subject to conditions that ensure the pro-competitive benefits clearly outweigh any potential adverse effects on competition. Importantly, the undertakings are required to avoid any form of price-fixing or collusive conduct, and pricing arrangements remain outside the scope of these exemptions. The pharmaceutical sector remains a priority area for CCP's exemption regime, with the Commission maintaining close coordination with relevant health regulators to ensure that such decisions serve the broader public interest. Copyright Business Recorder, 2025
Business Recorder
a day ago
- Business Recorder
CCP grants six exemptions to pharma sector
The Competition Commission of Pakistan (CCP) has granted six exemptions to undertakings in the pharmaceutical sector for the fiscal year 2024–25, under Section 5 of the Competition Act, 2010, read a press statement on Thursday. These exemptions relate to specific restrictive clauses in commercial agreements—such as territorial exclusivity and non-compete provisions—that would ordinarily be considered anti-competitive under Section 4 (Prohibited Agreements) of the Act, CCP said. However, after conducting rigorous due diligence, including a detailed assessment of market structures, sector-specific regulations, and the commercial terms of the agreements, CCP determined that the arrangements in question contribute to production efficiency, technological advancement, and enhanced consumer access to critical pharmaceutical products. The commission noted that these exemptions are expected to improve service delivery, increase the availability of medicines in underserved regions, and lead to better public health outcomes. 'Consumers stand to benefit from access to advanced pharmaceutical technologies, more reliable product information, and higher standards of service,' it said. The commission informed that each exemption was granted for a specific duration and is subject to conditions that ensure the pro-competitive benefits clearly outweigh any potential adverse effects on competition. 'Importantly, the undertakings are required to avoid any form of price-fixing or collusive conduct, and pricing arrangements remain outside the scope of these exemptions,' the commission stated. On Wednesday, the federal government, in an effort to boost pharmaceutical exports, announced the establishment of an empowered Pharma Export Promotion Council, PharmEx Pakistan, under the Trade Development Authority of Pakistan.
